title: Relationship of calcification of atherosclerotic plaque and arterial stiffness to bone mineral density and osteoprotegerin in postmenopausal women referred for osteoporosis screening.
abstract: Arterial calcification leading to increased arterial stiffness, a powerful risk factor for cardiovascular disease, may underlie the association of osteoporosis with cardiovascular disease in postmenopausal women. Osteoprotegerin (OPG), an indirect inhibitor of osteoclastogenesis, may be involved in arterial calcification. We examined relationships between calcification of subclinical atherosclerotic plaque and arterial stiffness with bone mineral density (BMD) and OPG in a group of 54 postmenopausal women referred for routine osteoporosis screening by dual-energy X-ray absorptiometric scanning of the lumbar spine and hip. Presence of calcified and noncalcified plaque in carotid and femoral arteries was examined using ultrasonography. Pulse wave velocity (PWV), a measure of arterial stiffness, was determined by sequential tonometry over the carotid and femoral region. Fifty-nine percent of osteoporotic women had calcified (echogenic) plaque at one or more sites compared with 42% and 20% for women with osteopenia and normal BMD, respectively (P = 0.04). There was a significant negative correlation between PWV and hip BMD (r = -0.35, P = 0.01), which remained significant when age, mean arterial pressure, and serum lipids were taken into account (P = 0.05). No significant relationships were observed between serum concentrations of OPG and lumbar spine or total hip BMD or with the number of arterial sites with calcified or noncalcified plaque. However, there was a strong correlation between OPG and PWV (r = 0.44, P = 0.001), which remained significant when adjusted for age (P = 0.01). These findings suggest that decreased BMD is associated with arterial calcification and stiffening and raise the possibility that OPG is a marker of arterial stiffening, independent of any association with BMD.
authors.affiliation: Osteoporosis Screening and Research Unit, King's College London, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK. michelle.frost@kcl.ac.uk
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Frost
authors.forename: Rodolpho
authors.initials: R
authors.lastname: Grella
authors.forename: Sandrine C
authors.initials: SC
authors.lastname: Millasseau
authors.forename: Ben-Yu
authors.initials: BY
authors.lastname: Jiang
authors.forename: Geeta
authors.initials: G
authors.lastname: Hampson
authors.forename: Ignac
authors.initials: I
authors.lastname: Fogelman
authors.forename: Phil J
authors.initials: PJ
authors.lastname: Chowienczyk
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D050197:Atherosclerosis / Q000097:blood / Q000000981:diagnostic imaging / Q000473:pathology*; D015415:Biomarkers / Q000378:metabolism; D015519:Bone Density / Q000502:physiology*; D002114:Calcinosis / Q000097:blood / Q000000981:diagnostic imaging / Q000473:pathology*; D002339:Carotid Arteries / Q000000981:diagnostic imaging / Q000473:pathology; D005260:Female; D006621:Hip Joint / Q000000981:diagnostic imaging / Q000378:metabolism; D006801:Humans; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging / Q000378:metabolism; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis*; D053244:Osteoprotegerin / Q000097:blood*; D011859:Radiography; D014463:Ultrasonography
chemical_list: D015415:Biomarkers; D053244:Osteoprotegerin